论文部分内容阅读
对晚期难以手术切除或术后复发的卵巢癌，以往主要应用各种方案的全身静脉化疗和腹腔化疗，疗效差，不良反应重，患者常难以耐受。随着介入放射学的发展，选择性骼内动脉插管化疗栓塞治疗各种盆腔恶性肿瘤技术已在临床广泛应用。然而，应用这种新技术和腹腔化疗联合治疗卵巢癌
Ovarian cancer, which is difficult to be surgically resected or recurred after surgery, has been used mainly in the past for various systemic intravenous and intraperitoneal chemotherapies. The curative effect is poor and the adverse reactions are serious. Patients are often difficult to tolerate. With the development of interventional radiology, selective intra-arterial catheterization of chemotherapy and embolization of various pelvic malignancies has been widely used in clinical practice. However, the combination of this new technology and intraperitoneal chemotherapy for ovarian cancer